SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P45
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -35.71% |
| Q3 2025 | -82.48% |
| Q2 2025 | 8.28% |
| Q1 2025 | 16.40% |
| Q4 2024 | -45.90% |
| Q3 2024 | 18.45% |
| Q2 2024 | 29.04% |
| Q1 2024 | 18.26% |
| Q4 2023 | -157.27% |
| Q3 2023 | -6.73% |
| Q2 2023 | -202.51% |
| Q1 2023 | -1743.98% |
| Q4 2022 | 101.20% |
| Q3 2022 | -63.06% |
| Q2 2022 | 53.55% |
| Q1 2022 | -50.48% |
| Q4 2021 | -1371.72% |
| Q3 2021 | 105.78% |
| Q2 2021 | -230.22% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |